Works by Fonseca, Rafael


Results: 263
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    The development of novel targeted therapeutics for treatment of multiple myeloma research roundtable.

    Published in:
    European Journal of Haematology, 2003, v. 70, n. 4, p. 263, doi. 10.1034/j.1600-0609.2003.t01-2-00011.x
    By:
    • Anderson, Kenneth C.;
    • Barlogie, Bart;
    • Berenson, James R.;
    • Dalton, William S.;
    • Adams, Julian;
    • Alsina, Melissa;
    • Bekker, Pirow;
    • Bergsagel, Peter L.;
    • Boise, Lawrence;
    • Chan, Kyle;
    • Chanan-Khan, Asher A.;
    • Comenzo, Raymond;
    • Congdon, Deborah;
    • Croucher, Peter;
    • Epstein, Joshua;
    • Fenton, Robert;
    • Fonseca, Rafael;
    • Gallant, Gilles;
    • Hussein, Mohamad A.;
    • Jagannath, Sundar
    Publication type:
    Article
    11
    12

    Anencefalia en un feto a término.

    Published in:
    Revista Habanera de Ciencias Médicas, 2023, v. 22, n. 4, p. 1
    By:
    • Santos Fonseca, Rafael Salvador;
    • Casado Méndez, Pedro Rafael
    Publication type:
    Article
    13
    14

    Plasma cell leukemia.

    Published in:
    2001
    By:
    • Hayman, Suzanne;
    • Fonseca, Rafael;
    • Hayman, S R;
    • Fonseca, R
    Publication type:
    journal article
    15
    16

    WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2025, v. 95, n. 1, p. 1, doi. 10.1007/s00280-024-04731-y
    By:
    • Oliveira-Silva, João Marcos;
    • Oliveira, Leilane Sales;
    • Chiminazo, Carolina Berraut;
    • Fonseca, Rafael;
    • de Souza, Carlos Vinicius Expedito;
    • Aissa, Alexandre Ferro;
    • de Almeida Lima, Graziela Domingues;
    • Ionta, Marisa;
    • Castro-Gamero, Angel Mauricio
    Publication type:
    Article
    17

    WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2025, v. 95, n. 1, p. 1, doi. 10.1007/s00280-024-04731-y
    By:
    • Oliveira-Silva, João Marcos;
    • Oliveira, Leilane Sales;
    • Chiminazo, Carolina Berraut;
    • Fonseca, Rafael;
    • de Souza, Carlos Vinicius Expedito;
    • Aissa, Alexandre Ferro;
    • de Almeida Lima, Graziela Domingues;
    • Ionta, Marisa;
    • Castro-Gamero, Angel Mauricio
    Publication type:
    Article
    18
    19

    Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 49, doi. 10.1002/ajh.26762
    By:
    • Ho, Matthew;
    • Zanwar, Saurabh;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan‐Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    20
    21
    22

    Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 5, p. E157, doi. 10.1002/ajh.26125
    By:
    • Wudhikarn, Kitsada;
    • Padrnos, Leslie;
    • Lasho, Terra;
    • LaPlant, Betsy;
    • Kumar, Shaji;
    • Dispenzieri, Angela;
    • Lacy, Martha;
    • Rajkumar, S. Vincent;
    • Gertz, Morie;
    • Mangaonkar, Abhishek A.;
    • Gonsalves, Wilson;
    • Ketterling, Rhett;
    • Shi, Chang‐Xin;
    • Fonseca, Rafael;
    • Stewart, A. Keith;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    23

    A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 467, doi. 10.1002/ajh.24693
    By:
    • Rosenthal, Allison;
    • Dueck, Amylou C.;
    • Ansell, Stephen;
    • Gano, Katherine;
    • Conley, Christopher;
    • Nowakowski, Grzegorz S.;
    • Camoriano, John;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Keith Stewart, A.;
    • Inwards, David;
    • Dingli, David;
    • Kumar, Shaji;
    • Noel, Pierre;
    • Gertz, Morie;
    • Porrata, Luis;
    • Russell, Stephen;
    • Colgan, Joseph;
    • Fonseca, Rafael;
    • Habermann, Thomas M.
    Publication type:
    Article
    24
    25

    Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial.

    Published in:
    American Journal of Hematology, 2011, v. 86, n. 8, p. 640, doi. 10.1002/ajh.22053
    By:
    • Kumar, Shaji K.;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Stewart, Keith;
    • Buadi, Francis K.;
    • Allred, Jacob;
    • Laumann, Kristina;
    • Greipp, Philip R.;
    • Lust, John A.;
    • Gertz, Morie A.;
    • Zeldenrust, Steven R.;
    • Bergsagel, P. Leif;
    • Reeder, Craig B.;
    • Witzig, Thomas E.;
    • Fonseca, Rafael;
    • Russell, Stephen J.;
    • Mikhael, Joseph R.;
    • Dingli, David;
    • Rajkumar, S. Vincent;
    • Dispenzieri, Angela
    Publication type:
    Article
    26

    Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma.

    Published in:
    American Journal of Hematology, 2010, v. 85, n. 9, p. 664, doi. 10.1002/ajh.21777
    By:
    • Gay, Francesca;
    • Rajkumar, S. Vincent;
    • Coleman, Morton;
    • Kumar, Shaji;
    • Mark, Tomer;
    • Dispenzieri, Angela;
    • Pearse, Roger;
    • Gertz, Morie A.;
    • Leonard, John;
    • Lacy, Martha Q.;
    • Chen-Kiang, Selina;
    • Roy, Vivek;
    • Jayabalan, David S.;
    • Lust, John A.;
    • Witzig, Thomas E.;
    • Fonseca, Rafael;
    • Kyle, Robert A.;
    • Greipp, Philip R.;
    • Stewart, A. Keith;
    • Niesvizky, Ruben
    Publication type:
    Article
    27

    A novel report of cig-FISH and cytogenetics in POEMS syndrome.

    Published in:
    American Journal of Hematology, 2008, v. 83, n. 11, p. 840, doi. 10.1002/ajh.21285
    By:
    • Bryce, Alan H.;
    • Ketterling, Rhett P.;
    • Gertz, Morie A.;
    • Lacy, Martha;
    • Knudson, Ryan A.;
    • Kumar, Shaji;
    • Kyle, Robert A.;
    • Fonseca, Rafael;
    • Greipp, Phillip R.;
    • Lust, John A.;
    • Rajkumar, Vincent S.;
    • Hayman, Suzanne R.;
    • Buadi, Francis;
    • Russell, Stephen J.;
    • Zeldenrust, Stephen R.;
    • Dispenzieri, Angela
    Publication type:
    Article
    28
    29
    30
    31

    Antiproliferative Activity of N -Acylhydrazone Derivative on Hepatocellular Carcinoma Cells Involves Transcriptional Regulation of Genes Required for G2/M Transition.

    Published in:
    Biomedicines, 2024, v. 12, n. 4, p. 892, doi. 10.3390/biomedicines12040892
    By:
    • Andrade, Amanda Aparecida Ribeiro;
    • Pauli, Fernanda;
    • Pressete, Carolina Girotto;
    • Zavan, Bruno;
    • Hanemann, João Adolfo Costa;
    • Miyazawa, Marta;
    • Fonseca, Rafael;
    • Caixeta, Ester Siqueira;
    • Nacif, Julia Louise Moreira;
    • Aissa, Alexandre Ferro;
    • Barreiro, Eliezer J.;
    • Ionta, Marisa
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38

    IgG replacement in multiple myeloma.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01107-6
    By:
    • Wonnaparhown, Alex;
    • Hilal, Talal;
    • Squire, Jacqueline;
    • Freeman, Catherine;
    • Fonseca, Rafael
    Publication type:
    Article
    39
    40
    41
    42
    43
    44

    Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
    By:
    • Bansal, Radhika;
    • Baksh, Mizba;
    • Larsen, Jeremy T.;
    • Hathcock, Matthew A.;
    • Dingli, David;
    • Stewart, A. Keith;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.;
    • Warsame, Rahma M.;
    • Fonseca, Rafael;
    • Bergsagel, P. Leif;
    • Ailawadhi, Sikander;
    • Kumar, Shaji K.;
    • Lin, Yi
    Publication type:
    Article
    45

    Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
    By:
    • Fonseca, Rodrigo;
    • Arribas, Mariano;
    • Wiedmeier-Nutor, Julia E.;
    • Kusne, Yael N.;
    • González Vélez, Miguel;
    • Kosiorek, Heidi E.;
    • Butterfield, Richard J.;
    • Kirsch, Ilan R.;
    • Mikhael, Joseph R.;
    • Stewart, A. Keith;
    • Reeder, Craig;
    • Larsen, Jeremy;
    • Bergsagel, P. Leif;
    • Fonseca, Rafael
    Publication type:
    Article
    46

    Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
    By:
    • Bansal, Radhika;
    • Baksh, Mizba;
    • Larsen, Jeremy T.;
    • Hathcock, Matthew A.;
    • Dingli, David;
    • Stewart, A. Keith;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.;
    • Warsame, Rahma M.;
    • Fonseca, Rafael;
    • Bergsagel, P. Leif;
    • Ailawadhi, Sikander;
    • Kumar, Shaji K.;
    • Lin, Yi
    Publication type:
    Article
    47

    Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
    By:
    • Fonseca, Rodrigo;
    • Arribas, Mariano;
    • Wiedmeier-Nutor, Julia E.;
    • Kusne, Yael N.;
    • González Vélez, Miguel;
    • Kosiorek, Heidi E.;
    • Butterfield, Richard J.;
    • Kirsch, Ilan R.;
    • Mikhael, Joseph R.;
    • Stewart, A. Keith;
    • Reeder, Craig;
    • Larsen, Jeremy;
    • Bergsagel, P. Leif;
    • Fonseca, Rafael
    Publication type:
    Article
    48
    49

    Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00752-z
    By:
    • Zanwar, Saurabh;
    • Ho, Matthew;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan-Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    50

    Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00680-y
    By:
    • Parrondo, Ricardo D.;
    • Rahman, Zaid Abdel;
    • Heckman, Michael G.;
    • Wieczorek, Mikolaj;
    • Jiang, Liuyan;
    • Alkhateeb, Hassan B.;
    • Litzow, Mark R.;
    • Greipp, Patricia;
    • Sher, Taimur;
    • Bergsagel, Leif;
    • Fonseca, Rafael;
    • Roy, Vivek;
    • Dispenzieri, Angela;
    • Kharfan-Dabaja, Mohamed A.;
    • Murthy, Hemant S.;
    • Ailawadhi, Sikander;
    • Foran, James M.
    Publication type:
    Article